Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors [Phase 2]
Clinical trial update reports completion of a Phase 2 study evaluating atrasentan to reduce albuminuria in patients with type 2 diabetes and…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating curcumin's effects on NFE2L2 gene expression, antioxidant capacity, and renal function in diabe…
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: PeRsOnalising Treatment Of Diabetic Nephropathy:
A clinical trial update notes completion of a study on personalized treatment for diabetic nephropathy in type 1 diabetes. The trial status …
-
FDA approval · 2018-04-09FDA Approved: VALSARTAN — Original Application (SQUARE PHARMACEUTICALS LIMITED)
The FDA approved Square Pharmaceuticals Limited's original application for valsartan (generic valsartan).
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Effect of Sulodexide in Early Diabetic Nephropathy [Phase 3]
Phase 3 trial of sulodexide in early diabetic nephropathy completed; results were posted in March 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-03-20Clinical Trial Update: Relation of Epicardial Fat and Diabetic Nephropathy in Egyptian Patients
A clinical trial update from Assiut University examining how epicardial fat relates to diabetic nephropathy in people with type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial evaluating medications for hypertension and hyperlipidemia in American Indians with Type 2 diabetes, focusing on di…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: A Study in Participants With Diabetic Kidney Disease [Phase 2]
Phase 2 study in participants with diabetic kidney disease was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Arterial Stiffness and Complication Risk in Type 2 Diabetes
A completed clinical trial investigating arterial stiffness and the risk of complications in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) [Phase 4]
Phase 4 clinical trial assessing immunosuppression effects on metabolic control in kidney transplant recipients with pre-existing type 2 dia…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy [Phase 2]
Phase 2 trial update for MT-3995 in diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan [Phase 2]
Phase 2 trial evaluating atrasentan to reduce residual albuminuria in people with diabetes and nephropathy has completed. The results may in…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Study of LY3016859 in Participants With Diabetic Nephropathy [Phase 1, Phase 2]
Phase 1/2 clinical trial of LY3016859 in participants with diabetic nephropathy completed; results posted in 2017.
-
CLINICAL_TRIALS research · 2017-07-25Clinical Trial Update: Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)
This is a clinical trial update for the PRECISED Substudy examining microalbuminuria as a cardiovascular risk factor, with endpoints related…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients [Phase 2]
Phase 2 clinical trial update for Acthar (repository corticotropin injection) in diabetic nephropathy with results posted.
-
FDA approval · 2017-07-21FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for ZESTRIL (lisinopril) submitted by Upsher-Smith Laboratories.
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy [NA]
Clinical trial update exploring serum immunoglobulin G as a biomarker for diabetic nephropathy; no status or results provided.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease
A retrospective analysis examines renal prognosis in patients with chronic kidney disease, highlighting conditions such as diabetic nephropa…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Delaying the Progression of Diabetic Nephropathy in Pima Indians
This clinical trial update reports on a completed study aimed at delaying the progression of diabetic nephropathy in Pima Indians.
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients
The document reports the completion of a clinical trial evaluating the effect of gastric bypass surgery on diabetes status and microvascular…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients [Phase 4]
Phase 4 trial results evaluating Pentoxifylline for reducing proteinuria in Korean patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL) [Phase 2, Phase 3]
This terminated IDEAL trial evaluated adding Vitamin D to losartan to reduce albuminuria in patients with diabetic nephropathy.
-
CLINICAL_TRIALS research · 2017-06-07Clinical Trial Update: Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy
This clinical trial update reports on hypothyroidism in patients with type 2 diabetes and early diabetic nephropathy. It is an ongoing study…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy [NA]
A completed clinical trial evaluating insulin pump therapy in patients with diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria [Phase 2]
Phase 2 study evaluating the safety and efficacy of adding aliskiren to standardized losartan and optimized antihypertensive therapy in pati…